UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Campus de Caparica, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal; CQE, Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa, Av Rovisco Pais, 1049-001 Lisboa, Portugal.
UCIBIO, Departamento Ciências da Vida, Faculdade de Ciências e Tecnologia, Campus de Caparica, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal.
J Control Release. 2017 Jan 10;245:52-61. doi: 10.1016/j.jconrel.2016.11.021. Epub 2016 Nov 18.
Due to their small size and unique properties, multifunctional nanoparticles arise as versatile delivery systems easily grafted with a vast array of functional moieties, such as anticancer cytotoxic chemotherapeutics and targeting agents. Here, we formulated a multifunctional gold-nanoparticle (AuNP) system composed of a monoclonal antibody against epidermal growth factor receptor (EGFR) (anti-EGFR D-11) for active targeting and a Co(II) coordination compound [CoCl(HO)(phendione)][BF] (phendione=1,10-phenanthroline-5,6-dione) (TS265) with proven antiproliferative activity towards cancer cells (designated as TargetNanoTS265). The efficacy of this nanoformulation, and the non-targeted counterpart (NanoTS265), were evaluated in vitro using cancer cell models and in vivo using mice xenografts. Compared to the free compound, both nanoformulations (TargetNanoTS265 and NanoTS265) efficiently delivered the cytotoxic cargo in a controlled selective manner due to the active targeting, boosting tumor cytotoxicity. Treatment of HCT116-derived xenografts tumors with TargetNanoTS265 led to 93% tumor reduction. This simple conceptual nanoformulation demonstrates the potential of nanovectorization of chemotherapeutics via simple assembly onto AuNPs of BSA/HAS-drug conjugates that may easily be expanded to suit other cargo of novel compounds that require optimized controlled delivery to cancer target.
由于多功能纳米粒子体积小、性质独特,因此很容易与各种功能基团(如抗癌细胞毒性化疗药物和靶向剂)接枝,成为多功能的输送系统。在这里,我们构建了一种多功能金纳米粒子(AuNP)系统,该系统由针对表皮生长因子受体(EGFR)的单克隆抗体(抗 EGFR D-11)组成,用于主动靶向,以及一种已被证明对癌细胞具有抗增殖活性的 Co(II)配位化合物 [CoCl(HO)(phendione)][BF](phendione=1,10-菲咯啉-5,6-二酮)(TS265)(指定为 TargetNanoTS265)。我们在体外使用癌细胞模型评估了这种纳米制剂和非靶向对照物(NanoTS265)的功效,并在体内使用小鼠异种移植模型进行了评估。与游离化合物相比,由于主动靶向,两种纳米制剂(TargetNanoTS265 和 NanoTS265)都以可控的选择性方式有效地递送了细胞毒性有效载荷,从而增强了肿瘤细胞毒性。用 TargetNanoTS265 治疗 HCT116 衍生的异种移植肿瘤,导致 93%的肿瘤缩小。这种简单的概念性纳米制剂证明了通过将 BSA/HAS-药物缀合物简单组装到 AuNPs 上来实现化学疗法的纳米载体化的潜力,这可能很容易扩展到需要优化控制递送到癌症靶标的其他新型化合物的有效载荷。